tetramethylpyrazine has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Z; Ji, Y; Lai, Y; Liu, J; Tian, J; Xu, J; Yan, C; Zhang, Y; Zhao, D; Zou, Y | 1 |
| Bian, Y; Li, W; Li, Z; Sheng, W; Xu, Y; Yang, L; Zeng, L | 1 |
2 other study(ies) available for tetramethylpyrazine and Colorectal Neoplasms
| Article | Year |
|---|---|
Novel Ligustrazine-Based Analogs of Piperlongumine Potently Suppress Proliferation and Metastasis of Colorectal Cancer Cells in Vitro and in Vivo.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Proliferation; Colorectal Neoplasms; Dioxolanes; Epithelial-Mesenchymal Transition; HCT116 Cells; Humans; Mice; Neoplasm Metastasis; Pyrazines; Reactive Oxygen Species; Solubility; Structure-Activity Relationship | 2018 |
Ligustrazine induces the colorectal cancer cells apoptosis via p53-dependent mitochondrial pathway and cell cycle arrest at the G0/G1 phase.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Colorectal Neoplasms; G1 Phase; Humans; Pyrazines; Signal Transduction; Tumor Suppressor Protein p53 | 2021 |